Could high c-peptide indicate insulin resistance or prediabetes?

High C-peptide levels often indicate insulin resistance or prediabetes, as your pancreas produces extra insulin to overcome cellular resistance to the hormone. Testing C-peptide alongside glucose and other metabolic markers provides crucial insights into your metabolic health before diabetes develops.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

If you've recently had blood work done and noticed high C-peptide levels, you might be wondering what this means for your health. C-peptide is a valuable biomarker that provides unique insights into how your pancreas produces insulin and how your body responds to it. Understanding C-peptide levels can help detect insulin resistance and prediabetes years before type 2 diabetes develops, giving you crucial time to make lifestyle changes that can prevent or delay disease progression.

While glucose and HbA1c tests show how much sugar is in your blood, C-peptide reveals the behind-the-scenes story of how hard your pancreas is working to maintain those glucose levels. This makes it an especially powerful tool for early detection of metabolic dysfunction, even when your blood sugar appears normal.

What Is C-Peptide and Why Does It Matter?

C-peptide (connecting peptide) is a protein that's produced in equal amounts to insulin by the beta cells in your pancreas. When your pancreas creates proinsulin, it splits into two parts: insulin and C-peptide. For every molecule of insulin released into your bloodstream, there's one molecule of C-peptide released alongside it.

C-Peptide Reference Ranges and Clinical Significance

C-Peptide Level (ng/mL)CategoryClinical SignificanceTypical Action
< 0.5< 0.5 ng/mLLowPossible type 1 diabetes or late-stage type 2Medical evaluation needed
0.5-2.00.5-2.0 ng/mLNormalHealthy insulin productionMaintain healthy lifestyle
2.1-3.02.1-3.0 ng/mLElevatedEarly insulin resistanceLifestyle modifications recommended
> 3.0> 3.0 ng/mLHighSignificant insulin resistanceAggressive lifestyle changes, consider medical consultation

C-peptide levels should be interpreted alongside glucose, HbA1c, and other metabolic markers for accurate assessment.

What makes C-peptide particularly useful as a biomarker is its stability and longer half-life compared to insulin. While insulin is quickly used by your cells and cleared from your bloodstream in about 5-10 minutes, C-peptide remains in circulation for 20-30 minutes. This longer presence makes it a more reliable indicator of insulin production over time.

The C-Peptide and Insulin Connection

Since C-peptide and insulin are produced in a 1:1 ratio, measuring C-peptide levels tells us exactly how much insulin your pancreas is producing. This is particularly valuable because:

  • It's not affected by injected insulin (important for people already on insulin therapy)
  • It provides a more stable measurement than insulin levels, which fluctuate rapidly
  • It can detect insulin production even when antibodies interfere with insulin tests
  • It helps distinguish between different types of diabetes

Normal vs. High C-Peptide Levels

Normal fasting C-peptide levels typically range from 0.5 to 2.0 ng/mL (or 0.17 to 0.67 nmol/L), though reference ranges can vary slightly between laboratories. After eating, C-peptide levels naturally rise as your pancreas releases insulin to help process glucose from your meal.

High C-peptide levels (above 2.0 ng/mL when fasting) suggest your pancreas is producing excessive amounts of insulin. This overproduction usually occurs because your cells have become resistant to insulin's effects, forcing your pancreas to compensate by making more.

How High C-Peptide Signals Insulin Resistance

Insulin resistance develops when your cells stop responding effectively to insulin's signal to absorb glucose from your bloodstream. Think of insulin as a key that unlocks your cells to let glucose in. When you have insulin resistance, it's like the locks on your cells have become rusty—you need more keys (insulin) to open the same number of doors.

Your pancreas responds to this resistance by producing more insulin to maintain normal blood glucose levels. This compensatory mechanism can work for years, keeping your glucose levels in the normal range while your insulin and C-peptide levels climb higher and higher. This is why many people with insulin resistance have normal glucose tests but elevated C-peptide levels.

The Progression from Insulin Resistance to Prediabetes

The journey from insulin resistance to prediabetes follows a predictable pattern:

  1. Initial insulin resistance: Cells become less responsive to insulin, but the pancreas compensates by producing more insulin (high C-peptide, normal glucose)
  2. Worsening resistance: The pancreas works harder to maintain glucose control (very high C-peptide, glucose may start to rise slightly)
  3. Prediabetes: The pancreas can no longer fully compensate, and glucose levels rise above normal but below diabetic thresholds
  4. Type 2 diabetes: Pancreatic function declines further, and glucose control is lost

Understanding where you are on this spectrum through comprehensive metabolic testing can help you take action before reaching the later stages. Regular monitoring of C-peptide alongside other metabolic markers provides the most complete picture of your metabolic health.

Symptoms and Risk Factors of High C-Peptide

High C-peptide levels often don't cause noticeable symptoms on their own. However, the underlying insulin resistance that drives elevated C-peptide can manifest in various ways:

Common Signs of Insulin Resistance

  • Difficulty losing weight, especially around the midsection
  • Increased hunger and cravings, particularly for carbohydrates
  • Fatigue after meals
  • Brain fog or difficulty concentrating
  • Skin changes like acanthosis nigricans (dark, velvety patches)
  • Skin tags
  • Irregular menstrual cycles in women
  • High blood pressure
  • Abnormal cholesterol levels (high triglycerides, low HDL)

Risk Factors for Developing High C-Peptide

Several factors increase your likelihood of developing insulin resistance and elevated C-peptide levels:

  • Family history of type 2 diabetes
  • Excess weight, particularly abdominal obesity
  • Sedentary lifestyle
  • Diet high in processed foods and added sugars
  • Chronic stress
  • Poor sleep quality or sleep apnea
  • Polycystic ovary syndrome (PCOS)
  • Certain medications (corticosteroids, some antipsychotics)
  • Age (risk increases after 45)
  • Ethnicity (higher risk in African American, Hispanic, Native American, and Asian populations)

Testing and Interpreting C-Peptide Results

C-peptide testing is typically done through a simple blood draw, either as a fasting test or as part of a glucose tolerance test. For the most accurate results, fasting C-peptide testing requires you to avoid food for 8-12 hours before the blood draw.

Understanding Your C-Peptide Results

Interpreting C-peptide results requires considering them in context with other metabolic markers. Here's what different C-peptide levels might indicate:

It's important to note that C-peptide levels alone don't diagnose insulin resistance or prediabetes. Your healthcare provider will consider these results alongside other tests like fasting glucose, HbA1c, insulin levels, and lipid panels to get a complete picture of your metabolic health.

Additional Tests to Consider

For a comprehensive assessment of metabolic health, consider these complementary tests:

  • Fasting insulin and HOMA-IR (to calculate insulin resistance)
  • Oral glucose tolerance test with insulin measurements
  • HbA1c (average blood sugar over 3 months)
  • Lipid panel (cholesterol and triglycerides)
  • Liver function tests (fatty liver is common with insulin resistance)
  • Inflammatory markers like hs-CRP
  • Thyroid function tests (thyroid issues can affect metabolism)

Managing High C-Peptide Levels Naturally

The good news about high C-peptide levels is that they're often reversible through lifestyle modifications. Since elevated C-peptide indicates your pancreas is still capable of producing insulin, you have an opportunity to improve your insulin sensitivity before more serious metabolic dysfunction develops.

Dietary Strategies

Your diet has the most immediate impact on insulin and C-peptide levels. Focus on these evidence-based approaches:

  • Reduce refined carbohydrates and added sugars
  • Increase fiber intake through vegetables, legumes, and whole grains
  • Include protein with every meal to slow glucose absorption
  • Choose healthy fats like olive oil, avocados, and nuts
  • Practice portion control and mindful eating
  • Consider time-restricted eating or intermittent fasting
  • Stay hydrated with water instead of sugary beverages

Exercise and Physical Activity

Regular physical activity is one of the most effective ways to improve insulin sensitivity. Both aerobic exercise and resistance training offer benefits:

  • Aim for at least 150 minutes of moderate aerobic activity weekly
  • Include 2-3 sessions of strength training per week
  • Take short walks after meals to help with glucose uptake
  • Break up long periods of sitting with movement breaks
  • Find activities you enjoy to ensure consistency

Lifestyle Modifications

Beyond diet and exercise, several lifestyle factors significantly impact insulin sensitivity:

  • Prioritize 7-9 hours of quality sleep nightly
  • Manage stress through meditation, yoga, or other relaxation techniques
  • Maintain a healthy weight (even 5-10% weight loss can improve insulin sensitivity)
  • Limit alcohol consumption
  • Quit smoking if applicable
  • Consider supplements like magnesium, chromium, or alpha-lipoic acid (consult your healthcare provider first)

When to Seek Medical Attention

While lifestyle changes can significantly improve insulin sensitivity and lower C-peptide levels, certain situations warrant medical evaluation and potential intervention:

  • C-peptide levels consistently above 4.0 ng/mL
  • Fasting glucose above 100 mg/dL or HbA1c above 5.7%
  • Symptoms of diabetes (excessive thirst, frequent urination, blurred vision)
  • Family history of type 2 diabetes with multiple risk factors
  • Difficulty losing weight despite lifestyle changes
  • Signs of metabolic syndrome (high blood pressure, abnormal cholesterol, abdominal obesity)

Your healthcare provider might recommend medications like metformin to improve insulin sensitivity, especially if you have prediabetes. However, medication should complement, not replace, lifestyle modifications.

Taking Control of Your Metabolic Health

High C-peptide levels serve as an early warning sign that your metabolic health needs attention. Unlike waiting until glucose levels rise to prediabetic or diabetic ranges, identifying elevated C-peptide gives you a valuable head start in preventing type 2 diabetes and its complications.

The key to success lies in regular monitoring and consistent lifestyle modifications. By tracking your C-peptide levels alongside other metabolic markers, you can see how your body responds to dietary changes, exercise, and other interventions. This feedback loop empowers you to make informed decisions about your health and catch any negative trends before they become serious problems.

Remember that reversing insulin resistance and normalizing C-peptide levels takes time—often several months to a year of consistent effort. Be patient with yourself and celebrate small victories along the way. With the right approach and regular monitoring, you can improve your insulin sensitivity, lower your C-peptide levels, and significantly reduce your risk of developing type 2 diabetes and other metabolic conditions.

References

  1. Jones, A. G., & Hattersley, A. T. (2013). The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabetic Medicine, 30(7), 803-817.[Link][PubMed][DOI]
  2. Leighton, E., Sainsbury, C. A., & Jones, G. C. (2017). A practical review of C-peptide testing in diabetes. Diabetes Therapy, 8(3), 475-487.[Link][PubMed][DOI]
  3. Patel, N., Taveira, T. H., Choudhary, G., Whitlatch, H., & Wu, W. C. (2012). Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults. Journal of the American Heart Association, 1(6), e003152.[PubMed][DOI]
  4. Li, Y., Meng, L., & Li, Y. (2019). C-peptide level as a marker of insulin resistance in patients with prediabetes. Experimental and Therapeutic Medicine, 18(3), 2104-2108.[PubMed][DOI]
  5. Abdullah, A., Hasan, H., & Raigangar, V. (2021). C-peptide versus insulin: relationships with risk biomarkers of cardiovascular disease in metabolic syndrome in young Arab females. International Journal of Endocrinology, 2021, 5513529.[PubMed][DOI]
  6. Kim, S. H., Reaven, G. M. (2013). Sex differences in insulin resistance and cardiovascular disease risk. Journal of Clinical Endocrinology & Metabolism, 98(11), E1716-E1721.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my C-peptide at home?

You can test your C-peptide at home with SiPhox Health's Heart & Metabolic Program, which includes C-peptide testing along with other essential metabolic markers. This CLIA-certified program provides lab-quality results from the comfort of your home, helping you track your insulin production and metabolic health over time.

What's the difference between C-peptide and insulin tests?

While both reflect insulin production, C-peptide is more stable and has a longer half-life than insulin (20-30 minutes vs 5-10 minutes). C-peptide isn't affected by injected insulin and provides a more accurate picture of your pancreas's insulin production. Additionally, C-peptide levels are less affected by liver clearance, making them a more reliable indicator of insulin secretion.

Can high C-peptide levels be reversed?

Yes, high C-peptide levels can often be reversed through lifestyle modifications. Improving insulin sensitivity through diet changes, regular exercise, weight loss, stress management, and adequate sleep can help normalize C-peptide levels. The key is addressing the underlying insulin resistance before it progresses to prediabetes or type 2 diabetes.

What C-peptide level indicates prediabetes?

There isn't a specific C-peptide cutoff for prediabetes diagnosis. Prediabetes is typically diagnosed based on fasting glucose (100-125 mg/dL) or HbA1c (5.7-6.4%). However, C-peptide levels above 2.0-3.0 ng/mL when fasting, especially when combined with other risk factors, suggest insulin resistance that may progress to prediabetes if not addressed.

How often should I test my C-peptide levels?

If you have elevated C-peptide or risk factors for insulin resistance, testing every 3-6 months is recommended to track your progress. This frequency allows you to see how lifestyle changes affect your insulin production and metabolic health. Once levels normalize, annual testing may be sufficient for monitoring.

What's the relationship between C-peptide and weight gain?

High C-peptide levels indicate high insulin production, and insulin is a storage hormone that promotes fat accumulation, especially around the midsection. This creates a cycle where insulin resistance leads to weight gain, which further worsens insulin resistance. Breaking this cycle through diet and exercise can help normalize both C-peptide levels and body weight.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details